| Nanomedicine in lung cancer: Current states of overcoming drug resistance and improving cancer immunotherapy W Wang, Y Hao, Y Liu, R Li, DB Huang, YY Pan Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology 13 (1 …, 2021 | 28 | 2021 |
| Metabolic glycan labeling immobilizes dendritic cell membrane and enhances antitumor efficacy of dendritic cell vaccine J Han, R Bhatta, Y Liu, Y Bo, A Elosegui-Artola, H Wang Nature communications 14 (1), 5049, 2023 | 14 | 2023 |
| T cell-responsive macroporous hydrogels for in situ T cell expansion and enhanced antitumor efficacy R Bhatta, J Han, Y Liu, Y Bo, H Wang Biomaterials 293, 121972, 2023 | 13 | 2023 |
| Metabolic tagging of extracellular vesicles and development of enhanced extracellular vesicle based cancer vaccines R Bhatta, J Han, Y Liu, Y Bo, D Lee, J Zhou, Y Wang, ER Nelson, Q Chen, ... Nature communications 14 (1), 8047, 2023 | 11 | 2023 |
| A double crosslinking adhesion mechanism for developing tough hydrogel adhesives J Han, J Park, R Bhatta, Y Liu, Y Bo, J Zhou, H Wang Acta Biomaterialia 150, 199-210, 2022 | 8 | 2022 |
| In Situ Dendritic Cell Recruitment and T Cell Activation for Cancer Immunotherapy J Han, R Bhatta, Y Liu, Y Bo, H Wang Frontiers in Pharmacology 13, 954955, 2022 | 8 | 2022 |
| Biomarkers and targeted therapy for cancer stem cells Y Liu, H Wang Trends in Pharmacological Sciences 45 (1), 56-66, 2024 | 4 | 2024 |
| Targeted delivery of liposomal chemoimmunotherapy for cancer treatment Y Liu, J Han, Y Bo, R Bhatta, H Wang Frontiers in immunology 13, 1010021, 2022 | 4 | 2022 |
| Primary adipocytes as targetable drug depot to prevent post-surgical cancer recurrence Y Bo, Y Wang, J Han, R Bhatta, Y Liu, D Baskaran, J Zhou, H Wang Materials Today Bio 25, 101020, 2024 | | 2024 |
| Unnatural lipids for simultaneous mRNA delivery and metabolic cell labeling Y Liu, J Zhou, Y Wang, D Baskaran, H Wang Biomaterials Science 12 (16), 4170-4180, 2024 | | 2024 |
